Published in Vopr Onkol on January 01, 2014
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 1.39
Breast self-examination for the early detection of breast cancer: a USSR/WHO controlled trial in Leningrad. Bull World Health Organ (1987) 1.29
[Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)]. Vopr Onkol (1999) 1.21
[Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer]. Vopr Onkol (2003) 1.18
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Glucose-induced effects and joker function of glucose: endocrine or genotoxic prevalence? Horm Metab Res (2006) 0.99
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Clinical trials on adjuvant chemotherapy for breast cancer. Cancer (1986) 0.92
[Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination]. Vopr Onkol (1996) 0.89
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol (2014) 0.89
CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol (2001) 0.87
[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume. Int J Androl (2002) 0.83
[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82
[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity]. Tsitologiia (2006) 0.82
[Some aspects of the regeneration process carried out by means of pluripotent stem cells]. Tsitologiia (2008) 0.81
Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients. J Cancer Res Clin Oncol (1996) 0.81
Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae (2010) 0.80
[Changes in the expression of receptors of steroid hormones in the development of partial androgen deficiency of aging men (PADAM)]. Tsitologiia (2005) 0.80
[A polymorphism study of the CYP19 gene in endometrial cancer patients]. Vopr Onkol (2000) 0.79
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79
[Immunologic reactivity of breast cancer patients]. Vopr Onkol (1978) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
[Comprehensive radiographic diagnosis of breast cancer]. Vopr Onkol (1996) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78
[Combined use of 99mTc-MIBI scintigraphy and ultrasonography (US) in the diagnosis of axillary lymphatic metastasis in patients with breast cancer]. Vopr Onkol (2013) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77
[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
Geographical distribution of breast cancer in the USSR. Int J Cancer (1984) 0.77
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
[Cognitive function in patients with endometrial and colorectal cancer: connection with hormonal and metabolic status]. Vopr Onkol (2004) 0.76
[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76
[Aromatase gene expression and its modifying factors in breast tumor tissue]. Vopr Onkol (1999) 0.76
[The role of breast cancer stem cells in metastasis]. Vopr Onkol (2015) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears. J Cancer Res Clin Oncol (2002) 0.76
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76
[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. Int J Cancer (1998) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75
[The effect of tobacco smoke on the uterotropic and genotoxic effects of estrogens in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1997) 0.75
[Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Molecular biological and biochemical features of breast cancer]. Vestn Ross Akad Med Nauk (1998) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)]. Vopr Onkol (1998) 0.75
[Relation of urinary excretion of cholesterol in cancer patients to certain hormonal-metabolic parameters and the effect of drugs on this relation]. Vopr Med Khim (1979) 0.75
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different age. Horm Metab Res (1999) 0.75
[Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Effects of tamoxifen and oxyprogesterone caproate on steroid hormone receptors in tumors and indicators of reproductive homeostasis in patients with cancer of the uterine body]. Akush Ginekol (Mosk) (1988) 0.75
[Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Vopr Onkol (1998) 0.75
[Tamoxifen-induced progesterone receptors in breast tumors]. Vopr Onkol (1991) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Study of steroid estrogens in their AZO compound forms by thin-layer chromatography on silica gels]. Probl Endokrinol (Mosk) (1969) 0.75
[State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. Vopr Onkol (1979) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett (1998) 0.75
[Effect of tobacco smoke on the level of estrogens and DNA in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer. Clin Exp Obstet Gynecol (1990) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75
[Ectopic endocrine syndromes]. Vopr Onkol (1968) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75